Cite
HARVARD Citation
Boddy, S. et al. (2022). Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis. Brain communications. 4 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boddy, S. et al. (2022). Unbiased metabolome screen leads to personalized medicine strategy for amyotrophic lateral sclerosis. Brain communications. 4 (2), p. . [Online].